Cargando…
Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer
INTRODUCTION: Around 90% of prostate cancers detected using the serum prostate specific antigen (PSA) as a screening test are considered to be localised. However, 20–30% of men treated by radical prostatectomy experience biochemical failure within two years of treatment. The presence of primary circ...
Autores principales: | Murray, Nigel P, Aedo, Sócrates, Reyes, Eduardo, Fuentealba, Cynthia, Jacob, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014557/ https://www.ncbi.nlm.nih.gov/pubmed/27610197 http://dx.doi.org/10.3332/ecancer.2016.671 |
Ejemplares similares
-
Combining the Prostate Cancer Risk Index (PRIX) with the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure after Radical Prostatectomy for Prostate Cancer
por: Murray, Nigel P, et al.
Publicado: (2018) -
10 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical Prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2018) -
Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome
por: Murray, Nigel P, et al.
Publicado: (2018) -
The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance
por: Murray, Nigel P, et al.
Publicado: (2017) -
Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2019)